S-8 EX-FILING FEES 0001681682 Fees to be Paid N/A 0001681682 1 2026-03-30 2026-03-30 0001681682 2026-03-30 2026-03-30 iso4217:USD xbrli:pure xbrli:shares

Ex-Filing Fees

CALCULATION OF FILING FEE TABLES

S-8

ENDRA Life Sciences Inc.

Table 1: Newly Registered Securities

                                       
Security Type   Security Class Title   Notes   Fee Calculation
Rule		   Amount Registered   Proposed Maximum Offering
Price Per Unit		   Maximum Aggregate Offering Price   Fee Rate   Amount of Registration Fee
                                       
Equity   Common Stock, $0.0001 par value per share, to be issued under the Registrant's 2016 Omnibus Incentive Plan   (1)   Other   3,200,000   $ 5.0325   $ 16,104,000.00   0.0001381   $ 2,223.97
                                       
Total Offering Amounts:   $ 16,104,000.00         2,223.97
Total Fee Offsets:               0.00
Net Fee Due:             $ 2,223.97

 

__________________________________________
Offering Note(s)

(1) 1a. Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement also covers such indeterminate number of additional shares of the Registrant’s common stock (“Common Stock”) as is necessary to eliminate any dilutive effect of any future stock split, stock dividend or similar transaction.

1b. Proposed Maximum Offering Price Per Unit is estimated solely for the purpose of calculating the registration fee pursuant to Rules 457(c) and 457(h) of the Securities Act and based on the average of the high and low prices for the Registrant’s Common Stock on May 11, 2026, as reported on The Nasdaq Capital Market.

1c. Represents 3,200,000 additional shares of Common Stock reserved for future issuance under the Registrant’s 2016 Omnibus Incentive Plan, as amended by the Second Amendment effective December 9, 2025.